A prescription for the US FDA for the regulation of health misinformation

被引：0

作者：

Kushal T. Kadakia

Adam L. Beckman

Harlan M. Krumholz

机构：

[1] Harvard Medical School,Department of Health Policy and Management

[2] Harvard Business School,Center for Outcomes Research and Evaluation

[3] Yale School of Public Health,Section of Cardiovascular Medicine, Department of Internal Medicine

[4] Yale New Haven Hospital,undefined

[5] Yale School of Medicine,undefined

来源：

Nature Medicine | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The US Food and Drug Administration should address health misinformation through existing and new regulatory approaches, including modernizing product labeling, investing in infodemic surveillance and addressing the roles of the internet and social media.

引用

页码：525 / 527

页数：2